Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of repeated low-dose erythropoietin (EPO) treatment on
necrotizing enterocolitis (NEC) in very preterm infants. Half of participants will receive
EPO, while the other half will receive a placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Zhengzhou University
Collaborators:
Göteborg University The First Affiliated Hospital of Zhengzhou University Women and Children Health Care Center of Luoyang, China Zhengzhou Children's Hospital, China